D. Western Therapeutics Institute, Inc.
D. Western Therapeutics Institute, Inc. (JPX: 4576) is trading at ¥70.00, about ₹42 at today's JPY/INR rate, as of 25 Sep 2026, 2:30 AM ET, down 1.41% today. Indian residents can buy D. Western Therapeutics Institute from India on Paasa under the RBI's Liberalised Remittance Scheme.
Quote
Today's low
¥70.00
Today's high
¥72.00
52 week low
¥66.00
52 week high
¥181.00
4576 opened at ¥71.00, closed previously at ¥71.00, and has traded between ¥66.00 and ¥181.00 over the past 52 weeks.
About
D. Western Therapeutics Institute, Inc. is a biotechnology enterprise focused on the research, discovery, and innovation of various pharmaceutical drugs. The company's current portfolio includes GLANATEC and GLA-ALPHA, ophthalmic solutions prescribed for glaucoma and ocular hypertension, as well as DW-1001, another medication for eye conditions. It also provides DWR-2206, a regenerative cell-based product targeting bullous keratopathy, and DW-1002, an ophthalmic surgical aid used for staining membranes like ILM, ALC, ERM, and PVR during cataract operations. In its development pipeline, the company is advancing DW-5LBT, a lidocaine patch designed to alleviate neuropathic pain post-shingles. Additionally, K-321 is progressing through Phase III clinical trials for Fuch endothelial corneal dystrophy, and H-1337, a multi-kinase inhibitor, has commenced Phase IIb trials for glaucoma and ocular hypertension treatment. The firm was established in 1999 and operates from its headquarters in Nagoya, Japan.
Key statistics
Avg. volume
349.22K
Market cap
¥4.02B
P/E Ratio
-5.88
Price-to-sales ratio
16.25
Enterprise value
¥3.02B
Free cash flow yield
0.00%
Debt-to-equity ratio
0.41
Return on equity
-45.41%
ROIC
-30.94%
Beta
-0.01
Dividend yield
0.00%
Last dividend
¥0.00
Financial overview
Revenue
¥387.62M
Earnings per share
-¥13.19
Free cash flow
-¥496.54M
Net profit margin
-257.89%
Gross margin
80.49%
EBITDA
-¥572.35M
Revenue growth
-17.80%
Similar securities
This is not an investment recommendation
How to buy D. Western Therapeutics Institute from India
Indian residents can buy D. Western Therapeutics Institute shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.
Open a Paasa account
Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Add funds under LRS
Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars and then to JPY.
Search for D. Western Therapeutics Institute and place an order
Find D. Western Therapeutics Institute by name or by its ticker, 4576, and choose an order type. The Tokyo Stock Exchange typically trades in units of 100 shares. D. Western Therapeutics Institute trades 5:30 am – 12:00 pm IST; orders can only execute during that window.
Track holdings and download tax reports
Follow your D. Western Therapeutics Institute position in JPY and INR. D. Western Therapeutics Institute pays no dividend today, so your filing is the capital-gains statement plus the Schedule FA holding line.
Read the full guide: how to invest in D. Western Therapeutics Institute from India
Trading and taxes when buying D. Western Therapeutics Institute from India
Trading and limits
- Trading hours
- 9:00 am – 3:30 pm JST
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- NoneD. Western Therapeutics Institute does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained
- Estate or inheritance tax
- May applyJapan levies inheritance tax on Japan-located assets such as direct stocks, with an exemption of ¥30 million plus ¥6 million per statutory heir.Estate tax explained
Custody. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
FAQs
Can Indian residents buy D. Western Therapeutics Institute stock?
Yes. D. Western Therapeutics Institute (4576) has been listed on the Tokyo Stock Exchange since 2009, in the Biotechnology industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars and then to JPY. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
How much does one D. Western Therapeutics Institute share cost in rupees?
One D. Western Therapeutics Institute share is ¥70.00 — about ₹42 at a JPY/INR rate of 0.6051 on 24 Sep 2026. Both the D. Western Therapeutics Institute price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for buying D. Western Therapeutics Institute from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.
What is the minimum I can buy of D. Western Therapeutics Institute?
The Tokyo Stock Exchange typically trades in units of 100 shares.
How are gains on D. Western Therapeutics Institute shares taxed in India?
Japan generally does not levy capital gains tax on non-resident individual investors, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the JPY/INR rate on the purchase and the sale date, so the rupee move counts alongside the D. Western Therapeutics Institute price. Paasa issues a capital-gains statement for your return.
Does D. Western Therapeutics Institute pay a dividend?
No. D. Western Therapeutics Institute does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one — dividends are taxed at your slab rate in India — and Paasa's dividend report would show the gross amount and any tax withheld.
When can I trade D. Western Therapeutics Institute from India?
The Tokyo Stock Exchange trades 5:30 am – 12:00 pm IST in Indian time. It also halts for lunch, 8:00 am – 9:00 am IST. Orders can only execute during that window.
Is there estate or inheritance tax on D. Western Therapeutics Institute shares held from India?
Japan levies inheritance tax on Japan-located assets such as direct stocks, with an exemption of ¥30 million plus ¥6 million per statutory heir. It applies to your overall holdings in that jurisdiction rather than to any one position.
Do I have to declare D. Western Therapeutics Institute shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your D. Western Therapeutics Institute holding, its cost and its closing value.
How do I sell D. Western Therapeutics Institute and bring the money back to India?
You sell during market hours (5:30 am – 12:00 pm IST) and the proceeds settle in JPY in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.